Role of Cdk5 in neuronal signaling, plasticity, and drug abuse

NeuroSignals

Volumn 12, Issue 4-5, 2003, Pages 191-199

  Bibb, James A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cdk5; DARPP 32; Drug abuse; Inhibitor 1; Kinase; Phosphatase; Plasticity

Indexed keywords

ALCOHOL; AMINO ACID DERIVATIVE; AMPA RECEPTOR; AMPHETAMINE; CALCINEURIN; CALCIUM CHANNEL; COCAINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE 5; DOPAMINE 1 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER RECEPTOR; NICOTINE; OPIATE; PHOSPHOPROTEIN DARPP 32; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN DERIVATIVE; TRANSCRIPTION FACTOR;

ADAPTATION; BASAL GANGLION; BRAIN DEVELOPMENT; DNA MICROARRAY; DRUG ABUSE; ENZYME ACTIVITY; HIPPOCAMPUS; LONG TERM EXPOSURE; LONG TERM POTENTIATION; MOLECULAR DYNAMICS; NEOSTRIATUM; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SYNAPTIC TRANSMISSION;

ANIMALS; CYCLIN-DEPENDENT KINASE 5; CYCLIN-DEPENDENT KINASES; MODELS, NEUROLOGICAL; NEOSTRIATUM; NEURONAL PLASTICITY; NEURONS; SIGNAL TRANSDUCTION; SUBSTANCE-RELATED DISORDERS;

EID: 0346119138     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074620     Document Type: Review

References (95)

1. Tokuda M, Hatase O: Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylation. Mol Neurobiol 1998;17:137-156.
2. Lisman J: A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory. Proc Natl Acad Sci USA 1989;86:9574-9578.
3. Lisman J: The CaM kinase II hypothesis for the storage of synaptic memory. Trends Neurosci 1994;17:406-412.
4. Soderling TR, Derkach VA: Postsynaptic protein phosphorylation and LTP. Trends Neurosci 2000;23:75-80.
5. Blank T, Nijholt I, Teichert U, Kugler H, Behrsing H, Fienberg A, Greengard P, Spiess J: The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses. Proc Natl Acad Sci USA 1997;94:14859-14864.
6. Snyder GL, Fienberg AA, Huganir RL, Greengard P: A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J Neurosci 1998;18:10297-10303.
7. Yan Z, Hsieh-Wilson L, Feng J, Tomizawa K, Allen PB, Fienberg AA, Nairn AC, Greengard P: Protein phosphatase 1 modulation of neostriatal AMPA channels: Regulation by DARPP-32 and spinophilin. Nat Neurosci 1999;2:13-17.
8. Strack S, Choi S, Lovinger DM, Colbran RJ: Translocation of autophosphorylated calcium/calmodulin-dependent protein kinase II to the postsynaptic density. J Biol Chem 1997;272:13467-13470.
9. Bito H, Deisseroth K, Tsien RW: CREB phosphorylation and dephosphorylation: A Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell Mol Biol 1996;87:1203-1214.
10. Mulkey RM, Endo S, Shenolikar S, Malenka RC: Involvement of calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature 1994;369:486-488.
11. Blitzer RD, Wong T, Nouranifar R, Iyengar R, Landau EM: Postsynaptic cAMP pathway gates early LTP in hippocampal CA1 region. Neuron 1995;15:1403-1414.
12. Blitzer RD, Connor JH, Brown GP, Wong T, Shenolikar S, Iyengar R, Landau EM: Gating of CaMKII by cAMP-regulated protein phosphatase activity during LTP. Science 1998;280:1940-1942.
13. Huang FL, Glinsmann WH: Separation and characterization of two phosphorylase phosphatase inhibitors from rabbit skeletal muscle. Eur J Biochem 1976;1976:419-426.
14. Morishita W, Connor JH, Xia H, Quinlan EM, Shenolikar S, Malenka RC: Regulation of synaptic strength by protein phosphatase 1. Neuron 2001;32:1133-1148.
15. Allen P, Hvalby Ø, Jensen V, Ramsay M, Chaudhry FA, Storm-Mathisen J, Morris R, Andersen P, Greengard P: Protein phosphatase-1 regulation in the induction of long-term potentiation: Heterogeneous molecular mechanisms. J Neurosci 2000;20:3537-3543.
16. Genoux D, Haditsch U, Knobloch M, Michalon A, Storm D, Mansuy IM: Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 2001;418:970-975.
17. Bibb JA, Nishi A, O'Callaghan JP, Ule J, Lan M, Snyder GL, Horiuchi A, Saito T, Hisanaga S, Czernik AJ, Nairn AC, Greengard P: Phosphorylation of protein phosphatase inhibitor-1 by Cdk5. J Biol Chem 2001;276:14490-14497.
18. 2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J Neurosci 2002;22:7879-7891.
19. Kennedy MB: Signal-processing machines at the postsynaptic density. Science 2000;290:750-754.
20. Sanes JR, Lichtman JW: Can molecules explain long-term potentiation? Nat Neurosci 1999;2:597-604.
21. Grant SGN, O'Dell TJ: Multiprotein complex signaling and the plasticity problem. Curr Opin Neurobiol 2001;11:363-368.
22. Sharma P, Veerana, Smarma M, Amin ND, Sihag RK, Grant P, Ahn N, Kulkarni AB, Pant HC: Phosphorylation of MEK1 by cdk5/p35 downregulates the mitogen-activated protein kinase pathway. J Biol Chem 2002;277:528-534.
23. Morabito MA, Sheng M, Tsai LH: Regulation of PSD-95 multimerization and clustering through direct phosphorylation by Cdk5. Program No 746.7, Abstract Viewer/Itinerary Planner. CD-ROM. Washington, Society for Neuroscience, 2002.
24. Li B-S, Sun M-K, Zhang L, Takahashi S, Ma W, Vinade L, Kulkarni AB, Brady RO, Pant HC: Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc Natl Acad Sci USA 2001;98:12742-12747.
25. Liu F, Ma X-H, Ule J, Bibb JA, Nishi JA, DeMaggio AJ, Yan Z, Nairn AC, Greengard P: Regulation of cyclin-dependent kinase 5 and casein kinase I by glutamate receptors. Proc Natl Acad Sci USA 2001;98:11062-11068.
26. Tomizawa K, Ohta J, Matsushita M, Moriwaki A, Li S, Takei K, Matsui H: Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J Neurosci 2002;22:2590-2597.
27. Tomizawa K, Cai XH, Moriwaki A, Matsushita M, Matsui H: Involvement of cyclin-dependent kinase 5/p35(nck5a) in the synaptic reorganization of rat hippocampus during kindling progression. Jpn J Physiol 2000;50:525-532.
28. Fischer A, Sananbenesi F, Schrick C, Spiess J, Radulovic J: Cyclin-dependent kinase 5 is required for associative learning. J Neurosci 2002;22:3700-3707.
29. Tessier-Lavigne M, Goodman CS: The molecular biology of axon guidance. Science 1996;274:1123-1133.
30. Bonhoeffer T, Yuste R: Spine motility. Phenomenology, mechanisms, and function. Neuron 2002;35:1019-1027.
31. Hubel DH, Wiesel TN: Receptive fields of cells in striate cortex of very young, visually inexperienced kittens. J Neurophysiology 1963;26:994-1002.
32. Hubel DH, Weisel TN: The period of susceptibility to the physiological effects of unilateral eye closure in kittens. J Physiol 1970;206:419-436.
33. Grutzendler J, Narayanan K, Gan W-B: Long-term dendritic spine stability in the adult cortex. Nature 2002;420:812-816.
34. Katz LC, Shatz CJ: Synaptic activity and construction of cortical circuits. Science 1996;274:1133-1138.
35. Yuste R, Bonhoeffer T: Morphological changes in dendritic spines associated with long-term synaptic plasticity. Annu Rev Neurosci 2001;24:1071-1089.
36. Trachtenberg JT, Chen BE, Knott GW, Feng G, Sanes JR, Welker E, Svoboda K: Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 2002;420:788-794.
37. Fischer M, Kaech S, Knutti D, Matus A: Rapid actin-based plasticity in dendritic spines. Neuron 1998;20:847-854.
38. Fischer M, Kaech S, Wagner U, Brinkhaus H, Matus A: Glutamate receptors regulate actin-based plasticity in dendritic spines. Nat Neurosci 2000;3:887-894.
39. Luo L: Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity. Annu Rev Cell Dev Biol 2002;18:601-635.
40. Meng Y, Zhang Y, Tregoubov V, Janus C, Cruz L, Jackson M, Lu WY, MacDonald JF, Wang JY, Falls DL, Jia Z: Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 2002;35:121-133.
41. Woolley C, Gould E, Frankfurt M, McEwen B: Naturally occurring fluctuations in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 1990;10:4035-4039.
42. Takeichi M: Cadherins: A molecular family important in selective cell-cell adhesion. Annu Rev Biochem 1990;59:235-252.
43. Ethell IM, Irie F, Kalo MS, Couchman JR, Pasquale EB, Yamaguchi Y: EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 2001;31:1001-1013.
44. Garcia RA, Vasudevan K, Buonanno A: The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci USA 2000;97:3596-3601.
45. Huang K-X, Paudel HK: Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor. Proc Natl Acad Sci USA 2000;97:5824-5829.
46. Horch HW, Kruttgen A, Portbury SD, Katz LC: Destabilization of cortical dendrites and spines by BDNF. Neuron 1999;23:353-364.
47. Hering H, Sheng M: Dendritic spines: Structure, dynamics and regulation. Nat Rev Neurosci 2001;2:880-888.
48. Tomita S, Nicoll RA, Bredt DS: PDZ protein interactions regulating glutamate receptor function and plasticity. J Cell Biol 2001;153:F19-F24.
49. Robinson TE, Kolb B: Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur J Neurosci 1999;11:1598-1604.
50. Robinson TE, Gorny G, Mitton E, Kolb B: Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001;39:257-266.
51. Norholm S, Bibb JA, Ouimet CC, Nestler EJ, Taylor JR, Greengard P: Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 2003;116:19-22.
52. Dhavan R, Tsai LH: A decade of CDK5. Nat Rev Mol Cell Biol 2001;2:749-759.
53. Smith DS, Greer PL, Tsai L-H: Cdk5 on the brain. Cell Growth Differ 2001;12:277-283.
54. Smith DS, Tsai L-H: Cdk5 behind the wheel: A role in trafficking and transport? Trends Cell Biol 2002;12:28-36.
55. Tan TC, Valova VA, Malladi CS, Graham ME, Berven LA, Jupp OJ, Hansra G, McClure SJ, Sarcevic B, Boadle RA, Larsen MR, Cousin MA, Robinson PJ: Cdk5 is essential for synaptic vesicle endocytosis. Nat Cell Biol 2003;5:701-710.
56. Nikolic M, Dudek H, Kwon YT, Ramos YF, Tsai LH: The Cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev 1996;10:816-825.
57. Nikolic M, Chou MM, Lu W, Mayer BJ, Tsai L-H: The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity. Nature 1998;395:194-198.
58. Sasaki Y, Cheng C, Uchida Y, Nakajima O, Ohshima T, Yagi T, Taniguchi M, Nakayama T, Kishida R, Kudo Y, Ohno S, Nakamura F, Goshima Y: Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron 2002;35:907-920.
59. Pigino G, Paglini G, Ulloa L, Avila J, Caceres A: Analysis of the expression, distribution and function of cyclin dependent kinase 5 (cdk5) in developing cerebellar macroneurons. J Cell Sci 1997;110:257-270.
60. Paglini G, Pigino G, Kunda P, Morfini G, Maccioni R, Quiroga S, Ferreira A, Caceres A: Evidence for the participation of the neuron-specific CDK5 activator P35 during laminin-enhanced axonal growth. J Neurosci 1998;18:9858-9869.
61. Kwon YT, Gupta A, Zhou Y, Nikolic M, Tsai LH: Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr Biol 2000;10:363-372.
62. Kesavapany S, Lau K-F, McLoughlin DM, Brownlees J, Ackerly S, Leigh PN, Shaw CE, Miller CCJ: p35/cdk5 binds and phosphorylates β-catenin/ presenilin-1 interactions. Eur J Neurosci 2001;13:241-247.
63. Fu AK, Fu WY, Cheung J, Tsim KW, Ip FC, Wang JH, Ip NY: Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 2001;4:374-381.
64. Sung KW, Choi S, Lovinger DM: Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses. J Neurophysiol 2001;86:2405-2412.
65. Centonze D, Picconi B, Gubellini P, Bernardi G, Calabresi P: Dopaminergic control of synaptic plasticity in the dorsal striatum. Eur J Neurosci 2001;12:1071-1077.
66. Kalivas PW: Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 1995;37:95-100.
67. Clark D, Overton PG: Alterations in excitatory amino acid-mediated regulation of midbrain dopaminergic neurons induced by chronic psychostimulant administration and stress: Relevance to behavioral sensitization and drug addiction. Addict Biol 1998;3:109-135.
68. Wolf ME: The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 1998;54:679-720.
69. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder G, Yan Z, Sagawa ZK, Quimet CC, Nairn AC, Nestler EJ, Greengard P: Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 2001;410:376-380.
70. Hyman SE, Malenka RC: Addiction and the brain: The neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001;2:695-703.
71. Hemmings HC Jr, Greengard P, Tung HYL, Cohen P: DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 1984;310:503-505.
72. Greengard P, Allen PB, Nairn AC: Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade. Neuron 1999;23:435-447.
73. Halpain S, Girault JA, Greengard P: Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 1990;343:369-372.
74. Bibb JA, Snyder GL, Nishi A, Yan Z, Meijer L, Fienberg AA, Tsai L-H, Kwon YT, Girault J-A, Czernik AJ, Huganir RL, Hemmings HC Jr, Nairn AC, Greengard P: Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signaling in neurons. Nature 1999;402:669-671.
75. Calabresi P, Gubellini P, Centonze D, Picconi B, Bernardi G, Chergui K, Svenningsson P, Fienberg AA, Greengard P: Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J Neurosci 2000;20:8443-8451.
76. Picconi B, Centonze D, Hakansson K, Bernardi G, Greengard P, Fisone G, Cenci MA, Calabresi P: Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 2003;6:501-506.
77. Wise RA: Brain dopamine and reward. Annu Rev Psychol 1989;40:191-225.
78. Koob GF, Nestler EJ: The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 1997;9:482-497.
79. Nestler EJ, Berhow MT, Brodkin ES: Molecular mechanisms of drug addiction: Adaptations in signal transduction pathways. Mol Psychiatry 1996;1:190-199.
80. Nestler EJ, Aghajanian GK: Molecular and cellular basis of addiction. Science 1997;278:58-63.
81. Berke JD, Paletzki RF, Aronson GJ, Hyman SE, Gerfen CR: A complex program of striatal gene expression induced by dopaminergic stimulation. J Neurosci 1998;18:5301-5310.
82. Nestler EJ: Genes and addiction. Nat Genet 2000;26:277-281.
83. Freeman WM, Nader MA, Nader SH, Robertson DJ, Gioia L, Mitchell SM, Daunais JB, Porrino LJ, Friedman DP, Vrana KE: Chronic cocaine-mediated changes in non-human primate nucleus accumbens gene expression. J Neurochem 2001;77:542-549.
84. Nestler EJ: Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001;2:119-128.
85. Nestler EJ, Landsman D: Learning about addiction from the genome. Nature 2001;409:834-835.
86. Kelz MB, Chen J, Carlezon WA Jr, Whisler K, Gilden L, Beckmann AM, Steffen C, Zhang Y-J, Marotti L, Self DW, Tkatch T, Baaranauskas G, Surmeier DJ, Neve RL, Duman RS, Picciotto MR, Nestler EJ: Expression of the transcriptional factor ΔFosB in the brain controls sensitivity to cocaine. Nature 1999;401:272-276.
87. Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Nairn AC, Nestler EJ, Greengard P: Regulation of the effects of cocaine by Cdk5 in dopaminoceptive neurons in the brain. Nature 2000;410:376-380.
88. Chen J, Zhang Y-J, Kelz MB, Steffen C, Ang ES, Zeng L, Nestler EJ: Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: Role of ΔFosB. J Neurosci 2000;10:8965-8971.
89. Brown JR, Ye H, Bronson RT, Dikkes P, Greenberg ME: A defect in nurturing in mice lacking the immediate early gene fosB. Cell 1996;86:297-309.
90. Hiroi N, Brown JR, Haile CN, Ye H, Greenberg ME, Nestler EJ: FosB mutant mice: Loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor rewarding effects. Proc Natl Acad Sci USA 1997;94:10397-20402.
91. Gupta A, Tsai LH: A kinase to dampen the effects of cocaine? Science 2001;293:277-283.
92. Robinson TE, Gorny G, Savage VR, Kolb B: Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 2002;46:271-279.
93. Ferrer-Alcon M, La Harpe R, Guimon J, Garcia-Sevilla JA: Downregulation of neuronal cdk5/p35 in opioid addicts and opiate-treated rats: Relation to neurofilament phosphorylation. Neuropsychopharmacology 2003;28:947-955.
94. Lindskog M, Svenningsson P, Pozzi L, Kim Y, Fienberg AA, Bibb JA, Fredholm BB, Nairn AC, Greengard P, Fisone G: Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 2002;418:774-778.
95. Winder DG, Sweatt JD: Roles of serine/threonine phosphatases in hippocampal synaptic plasticity. Nat Rev Neurosci 2001;2:461-474.